ACR Meeting Abstracts
Abstract Number: 1099 • ACR/ARHP Annual Meeting 2017
Yassir Daghistani1, Fergus To2, Patrick Doyle3,4, Hin Hin Ko5, Mel Krajden3,4, Jason Kur2, Alnoor Ramji6, Kam Shojania2, Edward Tam5, John Wade2, Eric Yoshida5, Graham Reid2, Siegfried Erb5 and Mollie Carruthers2, 1Medicine, University of British Columbia, Vancouver, BC, Canada, 2Rheumatology, University of British Columbia, Vancouver, BC, Canada, 3Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada, 4BC Centre for Disease Control, Vancouver, BC, Canada, 5Gastroenterology, University of British Columbia, Vancouver, BC, Canada, 6Gatroenterology, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: The widespread usage of biologic disease modifying anti-rheumatic drugs (bDMARDs) in rheumatology has increased the risk of hepatitis B virus (HBV) re-activation. The prevalence…